Amalgamated Bank Becton Dickinson & CO Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Becton Dickinson & CO stock. As of the latest transaction made, Amalgamated Bank holds 56,768 shares of BDX stock, worth $12.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
56,768
Previous 58,394 2.78%
Holding current value
$12.7 Million
Previous $13.6 Million 0.29%
% of portfolio
0.11%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$221.47 - $242.41 $360,110 - $394,158
-1,626 Reduced 2.78%
56,768 $13.7 Million
Q2 2024

Aug 12, 2024
SELL
$225.07 - $246.17 $332,203 - $363,346
-1,476 Reduced 2.47%
58,394 $13.6 Million
Q1 2024

Apr 23, 2024
SELL
$233.45 - $247.73 $2.43 Million - $2.58 Million
-10,405 Reduced 14.81%
59,870 $14.8 Million
Q4 2023

Feb 06, 2024
SELL
$232.24 - $267.23 $654,220 - $752,786
-2,817 Reduced 3.85%
70,275 $17.1 Million
Q3 2023

Nov 08, 2023
BUY
$254.9 - $283.59 $155,234 - $172,706
609 Added 0.84%
73,092 $18.9 Million
Q2 2023

Aug 11, 2023
SELL
$238.39 - $265.32 $449,841 - $500,658
-1,887 Reduced 2.54%
72,483 $19.1 Million
Q1 2023

May 02, 2023
SELL
$229.71 - $259.35 $39,969 - $45,126
-174 Reduced 0.23%
74,370 $18.4 Million
Q4 2022

Feb 10, 2023
SELL
$218.29 - $256.91 $89,935 - $105,846
-412 Reduced 0.55%
74,544 $19 Million
Q3 2022

Nov 09, 2022
BUY
$51.03 - $264.23 $90,527 - $468,744
1,774 Added 2.42%
74,956 $16.7 Million
Q2 2022

Aug 15, 2022
BUY
$234.74 - $275.42 $273,002 - $320,313
1,163 Added 1.61%
73,182 $18 Million
Q1 2022

Jun 30, 2022
SELL
$243.64 - $270.48 $1.26 Million - $1.4 Million
-5,176 Reduced 6.71%
72,019 $19.2 Million
Q4 2021

Feb 15, 2022
SELL
$230.08 - $250.94 $102,615 - $111,919
-446 Reduced 0.57%
77,195 $19.4 Million
Q3 2021

Oct 29, 2021
SELL
$232.72 - $256.47 $874,329 - $963,557
-3,757 Reduced 4.62%
77,641 $19.1 Million
Q2 2021

Aug 16, 2021
BUY
$232.65 - $254.58 $15.3 Million - $16.7 Million
65,622 Added 415.96%
81,398 $19.8 Million
Q1 2021

May 13, 2021
SELL
$232.09 - $256.88 $9,051 - $10,018
-39 Reduced 0.25%
15,776 $3.84 Million
Q4 2020

Feb 12, 2021
SELL
$221.92 - $245.94 $5,548 - $6,148
-25 Reduced 0.16%
15,815 $3.86 Million
Q3 2020

Oct 30, 2020
SELL
$215.77 - $276.76 $27,187 - $34,871
-126 Reduced 0.79%
15,840 $3.69 Million
Q2 2020

Aug 10, 2020
SELL
$219.9 - $263.41 $5.2 Million - $6.22 Million
-23,625 Reduced 59.67%
15,966 $3.82 Million
Q1 2020

May 13, 2020
SELL
$195.69 - $279.01 $292,556 - $417,119
-1,495 Reduced 3.64%
39,591 $9.1 Million
Q4 2019

Feb 13, 2020
BUY
$236.45 - $266.82 $657,331 - $741,759
2,780 Added 7.26%
41,086 $11.2 Million
Q3 2019

Nov 13, 2019
BUY
$230.58 - $256.08 $16,832 - $18,693
73 Added 0.19%
38,306 $9.69 Million
Q2 2019

Aug 14, 2019
BUY
$217.4 - $246.08 $835,685 - $945,931
3,844 Added 11.18%
38,233 $9.64 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $225,418 - $271,497
1,094 Added 3.29%
34,389 $8.59 Million
Q4 2018

Feb 15, 2019
SELL
$204.73 - $257.93 $134,302 - $169,202
-656 Reduced 1.93%
33,295 $7.5 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $195,312 - $214,528
-838 Reduced 2.41%
33,951 $8.86 Million
Q2 2018

Jul 18, 2018
SELL
$208.1 - $233.85 $805,971 - $905,701
-3,873 Reduced 10.02%
34,789 $8.33 Million
Q1 2018

May 22, 2018
BUY
$205.46 - $240.27 $1.85 Million - $2.16 Million
9,003 Added 30.36%
38,662 $8.38 Million
Q4 2017

Feb 13, 2018
BUY
$189.0 - $222.64 $498,393 - $587,101
2,637 Added 9.76%
29,659 $6.35 Million
Q3 2017

Nov 09, 2017
BUY
$186.89 - $198.9 $5.05 Million - $5.37 Million
27,022
27,022 $5.3 Million

Others Institutions Holding BDX

# of Institutions
1,737
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email